Subscribe for the Newsletter

Mobile Navigation

Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home

Takeda and Enzyre to Develop Diagnostic Device Allowing Hemophilia Patients to Determine their Coagulation Status at Home

N
Nice Insight

Dec 6, 2019PA1893

Under terms of the agreement, Enzyre will receive funding from Takeda to further tailor its existing technology.

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Explore
About UsNice InsightThat's Nice
Reach Our Team
Contact UsAdvertiseLinkedIn
My Account
LoginSign up
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.
Privacy PolicyTerms And Conditions